Vectura appoints Mark Bridgewater as chief commercial officer9 Mar 2020
Inhalation-focused CDMO Vectura said Monday it has appointed Mark Bridgewater as chief commercial officer, a new role focused on driving business development and growth in the pharmaceutical services space.
In his new role, Bridgewater has been tasked with implementing sales processes and building out a commercial team.
“He comes to the company with an impressive track record of delivering sustained growth and market success in each of his previous roles,” said Vectura CEO Will Downie. “His versatile leadership skills and growth mindset will help accelerate the transformation of the company into a true leader in the outsourcing space.”
With more than 20 years’ experience in medical device and pharmaceutical services, Bridgewater was previously VP business development and account management for Europe and Asia at Flex, a design, engineering and manufacturing organisation.
Prior to that, he worked as VP global business development, advanced delivery technologies at Catalent and has previously held roles at Wockhardt and Patheon.
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation